6505--HYGEN - ACAMPROSATE - 36C77026Q0124

The contract pertains to the procurement of 1,440 blister packs of ACAMPROSATE CA 333MG EC TAB 180CT (NDC: 68462-0435-18) under a small business set-aside, with solicitation number 36C77026Q0124 issued by the Department of Veterans Affairs through the National Cmop Office in Leavenworth, Kansas. Delivery is required within 10 days after receipt of order to the Great Lakes CMOP in Hines, Illinois, under FOB destination terms, meaning risk of loss transfers to the Government upon arrival. The contractor must adhere to stringent pharmaceutical packaging, labeling, and preservation standards, including minimum 12-month expiration dating from delivery, use of FDA therapeutic equivalence code “A” (with limited exceptions), and compliance with the Drug Supply Chain Security Act. Bar code labeling must conform to GS1-128, HIBCC, or HIBC standards with ANSI/ISO/IEC Grade C or higher print quality, encoding the NDC and lot/expiry data on each blister cell without spanning perforations. Only original manufacturer packaging is permitted unless otherwise approved, with a minimum 100cc bottle size, child-safety cap, and specific dimensional requirements. Substitutions of pack sizes, dosage forms, or partial deliveries require prior written authorization from the Contracting Officer, and no more than three lot numbers may be included per shipment without approval. Contract administration is managed by the Contracting Officer, Kelley Cunningham, at the NCO 15 Contracting Office in Leavenworth, with no assigned COR/COTR specified. Payment must be submitted electronically via the System for Award Management under Electronic Funds Transfer using VAAR Clause 852.232-72, and invoices must comply with VA-specific electronic submission protocols. The contract incorporates multiple modified FAR clauses, including deviations for whistleblower rights, prohibition on internal confidentiality agreements, small business set-aside representation, child labor protections, and equal opportunity for workers with disabilities. Offerors must hold a valid Unique Entity Identifier, certify their small business status under the SBA total set-aside, and meet all representations under FAR 52.212-3, including Buy American and whistleblower protections. The award will be made to the most advantageous offer based on trade-off considerations including price, delivery capability, past performance, and technical compliance—not a lowest price technically acceptable approach